Quick Answer
ACADIA PHARMACEUTICALS INC reported Net Income of $391.00 million for fiscal year 2025.
ACADIA PHARMACEUTICALS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $391.00M | +72.7% |
| 2024 | $226.45M | +469.5% |
| 2023 | -$61.29M | +71.6% |
| 2022 | -$215.97M | -28.7% |
| 2021 | -$167.87M | +40.4% |
| 2020 | -$281.58M | -19.7% |
| 2019 | -$235.26M | +4.1% |
| 2018 | -$245.19M | +15.3% |
| 2017 | -$289.40M | -6.6% |
| 2016 | -$271.39M | -65.0% |
| 2015 | -$164.44M | -77.8% |
| 2014 | -$92.47M | -143.7% |
| 2013 | -$37.95M | -82.0% |
| 2012 | -$20.85M | +8.4% |
| 2011 | -$22.77M | -250.4% |
| 2010 | $15.14M | +133.5% |
| 2009 | -$45.15M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $71.78M | +119.1% | +169.2% |
| June 30, 2025 | $26.67M | -20.1% | +40.4% |
| March 31, 2025 | $18.99M | +14.7% | -42.1% |
| September 30, 2024 | $32.77M | +150.3% | -1.9% |
| June 30, 2024 | $33.39M | +2897.2% | +101.7% |
| March 31, 2024 | $16.55M | +138.5% | +125.4% |
| September 30, 2023 | -$65.18M | -139.8% | -5950.6% |
| June 30, 2023 | $1.11M | +103.3% | +102.6% |
- ACADIA PHARMACEUTICALS INC showed an increase of +72.7% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, ACADIA PHARMACEUTICALS INC’s net income has grown by 966.1% (from -$45.15 million to $391.00 million).
- The most recent figure is from ACADIA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: